

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.69026606 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.68931248 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.53702654 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.37387308 |
| 5 | negative regulation of cell killing (GO:0031342) | 6.04806910 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.04806910 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.21318548 |
| 8 | immunoglobulin mediated immune response (GO:0016064) | 5.10421359 |
| 9 | detection of bacterium (GO:0016045) | 4.74940192 |
| 10 | cellular response to type I interferon (GO:0071357) | 4.74195466 |
| 11 | type I interferon signaling pathway (GO:0060337) | 4.74195466 |
| 12 | response to type I interferon (GO:0034340) | 4.69888435 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.67890646 |
| 14 | detection of other organism (GO:0098543) | 4.57638892 |
| 15 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.35532993 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 4.17907369 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.17904144 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.17904144 |
| 19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.17904144 |
| 20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.17904144 |
| 21 | modulation by symbiont of host immune response (GO:0052553) | 4.17904144 |
| 22 | positive regulation by symbiont of host defense response (GO:0052509) | 4.17904144 |
| 23 | B cell mediated immunity (GO:0019724) | 4.13145910 |
| 24 | response to interleukin-15 (GO:0070672) | 4.11489700 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.06143107 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93532656 |
| 27 | negative thymic T cell selection (GO:0045060) | 3.86774918 |
| 28 | negative T cell selection (GO:0043383) | 3.84314015 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 3.81854553 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.77174216 |
| 31 | leukocyte aggregation (GO:0070486) | 3.76277376 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.73916503 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.71512929 |
| 34 | T cell migration (GO:0072678) | 3.70098874 |
| 35 | positive thymic T cell selection (GO:0045059) | 3.68181564 |
| 36 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.65791005 |
| 37 | cytidine metabolic process (GO:0046087) | 3.65634936 |
| 38 | cytidine catabolic process (GO:0006216) | 3.65634936 |
| 39 | cytidine deamination (GO:0009972) | 3.65634936 |
| 40 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.62595344 |
| 41 | regulation of T cell tolerance induction (GO:0002664) | 3.62180890 |
| 42 | B cell receptor signaling pathway (GO:0050853) | 3.61294882 |
| 43 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.60003668 |
| 44 | myeloid dendritic cell differentiation (GO:0043011) | 3.58037686 |
| 45 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.56476931 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.55327864 |
| 47 | T-helper 1 type immune response (GO:0042088) | 3.53434559 |
| 48 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.52534169 |
| 49 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.52534169 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 3.47685813 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.44985096 |
| 52 | response to peptidoglycan (GO:0032494) | 3.43969471 |
| 53 | cellular response to interferon-gamma (GO:0071346) | 3.40923140 |
| 54 | respiratory burst (GO:0045730) | 3.39591983 |
| 55 | detection of external biotic stimulus (GO:0098581) | 3.39495871 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 3.39248732 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.39144069 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 3.37268920 |
| 59 | response to interferon-beta (GO:0035456) | 3.34256381 |
| 60 | thymic T cell selection (GO:0045061) | 3.29326804 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29291124 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.27582546 |
| 63 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.27234091 |
| 64 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.26753968 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26738575 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 3.24899196 |
| 67 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.24574896 |
| 68 | defense response to protozoan (GO:0042832) | 3.24193113 |
| 69 | regulation of tolerance induction (GO:0002643) | 3.19440433 |
| 70 | T cell costimulation (GO:0031295) | 3.16786937 |
| 71 | response to interferon-gamma (GO:0034341) | 3.14996316 |
| 72 | lymphocyte costimulation (GO:0031294) | 3.14161101 |
| 73 | negative regulation of innate immune response (GO:0045824) | 3.14055253 |
| 74 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.12455497 |
| 75 | negative regulation of viral genome replication (GO:0045071) | 3.11948490 |
| 76 | response to protozoan (GO:0001562) | 3.06232986 |
| 77 | positive T cell selection (GO:0043368) | 3.05604136 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04892704 |
| 79 | * positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.04638481 |
| 80 | T cell selection (GO:0045058) | 3.02761574 |
| 81 | regulation of B cell differentiation (GO:0045577) | 3.01488024 |
| 82 | regulation of regulatory T cell differentiation (GO:0045589) | 3.00598196 |
| 83 | * regulation of cell killing (GO:0031341) | 2.98938315 |
| 84 | positive regulation of humoral immune response (GO:0002922) | 2.98237489 |
| 85 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.98002148 |
| 86 | tolerance induction (GO:0002507) | 2.97089625 |
| 87 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.95618870 |
| 88 | detection of biotic stimulus (GO:0009595) | 2.95511956 |
| 89 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.94135885 |
| 90 | positive regulation of B cell mediated immunity (GO:0002714) | 2.94135885 |
| 91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.92602379 |
| 92 | response to host immune response (GO:0052572) | 2.92602379 |
| 93 | * positive regulation of cell killing (GO:0031343) | 2.91738491 |
| 94 | positive regulation of interferon-alpha production (GO:0032727) | 2.88927417 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 2.88830651 |
| 96 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.87321593 |
| 97 | regulation of interleukin-12 production (GO:0032655) | 2.86734926 |
| 98 | response to interferon-alpha (GO:0035455) | 2.86301736 |
| 99 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85905180 |
| 100 | germinal center formation (GO:0002467) | 2.84929411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.46744195 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.92115649 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.22081337 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.95964687 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.56228013 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.55025711 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.17797674 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.02992859 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.99060563 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.95626510 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.92345586 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.62855869 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.58943955 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.48589549 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48028654 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46507565 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.45833222 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37447636 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.34815297 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28160740 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25882971 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.25724519 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.24299542 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.23078390 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21138191 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.18011275 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.15891365 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14954176 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94295913 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93005589 |
| 31 | * MAF_26560356_Chip-Seq_TH2_Human | 1.89118813 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88333707 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77282571 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73568054 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72273573 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70277460 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69117950 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68788450 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65185755 |
| 40 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64161950 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61934676 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57508153 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52089986 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50737119 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49989078 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47800615 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47236407 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43222652 |
| 49 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41347375 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37020657 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36857107 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36780210 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36235397 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33583171 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30672200 |
| 56 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30570387 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30565135 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28747791 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28427560 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.28334081 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26693095 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26650350 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25988111 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25709600 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25118171 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22872265 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18951945 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18614999 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17863935 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16445339 |
| 71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15153844 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15080173 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14091371 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12709535 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08629339 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08155005 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06809339 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06342913 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03660423 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03657097 |
| 81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99230046 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97186675 |
| 83 | P300_27268052_Chip-Seq_Bcells_Human | 0.95853068 |
| 84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93680135 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93067445 |
| 86 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92550429 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92489850 |
| 88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91730319 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91223683 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90971300 |
| 91 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89797139 |
| 92 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88308185 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88053267 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 0.88048103 |
| 95 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.87832149 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86837854 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85320482 |
| 98 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85316600 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85240793 |
| 100 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84921059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.35902271 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.29405483 |
| 3 | MP0003436_decreased_susceptibility_to | 3.89623434 |
| 4 | MP0000685_abnormal_immune_system | 3.77825340 |
| 5 | MP0003724_increased_susceptibility_to | 3.56620763 |
| 6 | MP0005387_immune_system_phenotype | 3.50228201 |
| 7 | MP0001790_abnormal_immune_system | 3.50228201 |
| 8 | MP0009785_altered_susceptibility_to | 3.36558475 |
| 9 | MP0001800_abnormal_humoral_immune | 3.31686053 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.29547340 |
| 11 | MP0003303_peritoneal_inflammation | 3.13002843 |
| 12 | MP0005025_abnormal_response_to | 2.97555757 |
| 13 | MP0002723_abnormal_immune_serum | 2.84489596 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.79476301 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.75805773 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.72599922 |
| 17 | MP0002419_abnormal_innate_immunity | 2.66682196 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.63570575 |
| 19 | MP0001819_abnormal_immune_cell | 2.60551819 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.51807779 |
| 21 | MP0006082_CNS_inflammation | 2.45456635 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.27918543 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.06847790 |
| 24 | MP0003183_abnormal_peptide_metabolism | 2.03247089 |
| 25 | MP0001845_abnormal_inflammatory_respons | 2.02500819 |
| 26 | MP0000716_abnormal_immune_system | 2.01384494 |
| 27 | MP0002398_abnormal_bone_marrow | 2.00748594 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.95519463 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.94798579 |
| 30 | MP0003866_abnormal_defecation | 1.90928576 |
| 31 | MP0002405_respiratory_system_inflammati | 1.90274434 |
| 32 | MP0004947_skin_inflammation | 1.81343126 |
| 33 | MP0001873_stomach_inflammation | 1.75636982 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.74416150 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.65487181 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.63282070 |
| 37 | MP0005310_abnormal_salivary_gland | 1.60894071 |
| 38 | MP0002429_abnormal_blood_cell | 1.60304300 |
| 39 | MP0002722_abnormal_immune_system | 1.59824542 |
| 40 | MP0008469_abnormal_protein_level | 1.59162752 |
| 41 | MP0004510_myositis | 1.51806717 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.46080432 |
| 43 | MP0009764_decreased_sensitivity_to | 1.41627508 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.38949074 |
| 45 | MP0009840_abnormal_foam_cell | 1.37589527 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.34220730 |
| 47 | MP0002006_tumorigenesis | 1.27889949 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.20386834 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.19426164 |
| 50 | MP0005166_decreased_susceptibility_to | 1.19418343 |
| 51 | MP0001853_heart_inflammation | 1.16163117 |
| 52 | MP0000858_altered_metastatic_potential | 1.15140260 |
| 53 | MP0008260_abnormal_autophagy | 1.14244921 |
| 54 | MP0005451_abnormal_body_composition | 1.13807672 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.10578731 |
| 56 | MP0000490_abnormal_crypts_of | 1.07342308 |
| 57 | MP0003075_altered_response_to | 1.06926786 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.04850490 |
| 59 | MP0002933_joint_inflammation | 1.04103408 |
| 60 | MP0003045_fibrosis | 1.02945648 |
| 61 | MP0009763_increased_sensitivity_to | 0.97692432 |
| 62 | MP0000343_altered_response_to | 0.97227766 |
| 63 | MP0003448_altered_tumor_morphology | 0.96863103 |
| 64 | MP0003172_abnormal_lysosome_physiology | 0.95885947 |
| 65 | MP0002254_reproductive_system_inflammat | 0.95662503 |
| 66 | MP0001663_abnormal_digestive_system | 0.94503403 |
| 67 | MP0002132_abnormal_respiratory_system | 0.93961002 |
| 68 | MP0009278_abnormal_bone_marrow | 0.92213122 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.90526260 |
| 70 | MP0005360_urolithiasis | 0.87584852 |
| 71 | MP0000604_amyloidosis | 0.84460388 |
| 72 | MP0005390_skeleton_phenotype | 0.82382465 |
| 73 | MP0002396_abnormal_hematopoietic_system | 0.80411592 |
| 74 | MP0001348_abnormal_lacrimal_gland | 0.76805007 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 0.73535576 |
| 76 | MP0000249_abnormal_blood_vessel | 0.69345954 |
| 77 | MP0001851_eye_inflammation | 0.68771832 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.67735074 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.66698988 |
| 80 | MP0004381_abnormal_hair_follicle | 0.66214575 |
| 81 | MP0004883_abnormal_blood_vessel | 0.65438151 |
| 82 | MP0003828_pulmonary_edema | 0.64852239 |
| 83 | MP0003795_abnormal_bone_structure | 0.64428480 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.63812964 |
| 85 | MP0009643_abnormal_urine_homeostasis | 0.63444633 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.62301176 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.62301176 |
| 88 | MP0000609_abnormal_liver_physiology | 0.61124168 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.58931238 |
| 90 | MP0005164_abnormal_response_to | 0.56114190 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.56002243 |
| 92 | MP0005381_digestive/alimentary_phenotyp | 0.54773600 |
| 93 | MP0008874_decreased_physiological_sensi | 0.52519812 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52458904 |
| 95 | MP0005165_increased_susceptibility_to | 0.51390734 |
| 96 | MP0008004_abnormal_stomach_pH | 0.50292665 |
| 97 | MP0005535_abnormal_body_temperature | 0.45497237 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.44103268 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.43501915 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.42803994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.96553318 |
| 2 | Abnormality of macrophages (HP:0004311) | 4.91517516 |
| 3 | Myositis (HP:0100614) | 4.91472837 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.85208312 |
| 5 | Orchitis (HP:0100796) | 4.71349928 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.70752682 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.62582628 |
| 8 | Optic neuritis (HP:0100653) | 4.59532228 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.59532228 |
| 10 | Meningitis (HP:0001287) | 4.53808977 |
| 11 | Vasculitis (HP:0002633) | 4.36563344 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.30078617 |
| 13 | Gastrointestinal stroma tumor (HP:0100723) | 4.28399637 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.16638531 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.93433113 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.87649383 |
| 17 | Stomatitis (HP:0010280) | 3.81530800 |
| 18 | Obstructive lung disease (HP:0006536) | 3.79267206 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.79267206 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.75247699 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.74871341 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.74845085 |
| 23 | Encephalitis (HP:0002383) | 3.72517136 |
| 24 | Increased IgM level (HP:0003496) | 3.58112184 |
| 25 | Urticaria (HP:0001025) | 3.57317311 |
| 26 | Pulmonary infiltrates (HP:0002113) | 3.53638518 |
| 27 | Lymphopenia (HP:0001888) | 3.49575449 |
| 28 | IgM deficiency (HP:0002850) | 3.44793735 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.42692185 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.42692185 |
| 31 | Recurrent skin infections (HP:0001581) | 3.40642321 |
| 32 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.40221143 |
| 33 | Recurrent sinusitis (HP:0011108) | 3.39408794 |
| 34 | Cellulitis (HP:0100658) | 3.35511074 |
| 35 | Chronic diarrhea (HP:0002028) | 3.34672903 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 3.30480898 |
| 37 | Abnormality of T cells (HP:0002843) | 3.28872934 |
| 38 | IgG deficiency (HP:0004315) | 3.28868843 |
| 39 | Recurrent viral infections (HP:0004429) | 3.25636980 |
| 40 | Increased IgE level (HP:0003212) | 3.24019807 |
| 41 | Abnormality of T cell number (HP:0011839) | 3.23408967 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 3.18864959 |
| 43 | T lymphocytopenia (HP:0005403) | 3.18619088 |
| 44 | Keratoconjunctivitis (HP:0001096) | 3.10448031 |
| 45 | Petechiae (HP:0000967) | 3.02380202 |
| 46 | Hemoptysis (HP:0002105) | 2.96822835 |
| 47 | Chest pain (HP:0100749) | 2.95991887 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.93515920 |
| 49 | Emphysema (HP:0002097) | 2.89779780 |
| 50 | IgA deficiency (HP:0002720) | 2.87569683 |
| 51 | Premature loss of primary teeth (HP:0006323) | 2.79728005 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.79032496 |
| 53 | Hypergammaglobulinemia (HP:0010702) | 2.72916730 |
| 54 | Gingivitis (HP:0000230) | 2.72239206 |
| 55 | Abnormality of the pleura (HP:0002103) | 2.72091837 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.70913939 |
| 57 | Chronic otitis media (HP:0000389) | 2.70223454 |
| 58 | Colitis (HP:0002583) | 2.67984068 |
| 59 | Osteomyelitis (HP:0002754) | 2.66276067 |
| 60 | Skin rash (HP:0000988) | 2.65657653 |
| 61 | Pustule (HP:0200039) | 2.65398475 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.63742544 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.60372266 |
| 64 | Restrictive lung disease (HP:0002091) | 2.59442163 |
| 65 | Recurrent pneumonia (HP:0006532) | 2.59398053 |
| 66 | Leukocytosis (HP:0001974) | 2.53124253 |
| 67 | Gangrene (HP:0100758) | 2.50664897 |
| 68 | Recurrent lower respiratory tract infections (HP:0002783) | 2.45013080 |
| 69 | Granulocytopenia (HP:0001913) | 2.44356275 |
| 70 | Pulmonary embolism (HP:0002204) | 2.39580704 |
| 71 | Arterial thrombosis (HP:0004420) | 2.38389791 |
| 72 | Anorexia (HP:0002039) | 2.35371775 |
| 73 | Sepsis (HP:0100806) | 2.35042421 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.34665275 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.34190461 |
| 76 | Purpura (HP:0000979) | 2.32991156 |
| 77 | Joint swelling (HP:0001386) | 2.31495999 |
| 78 | Hypochromic anemia (HP:0001931) | 2.29890557 |
| 79 | Arthralgia (HP:0002829) | 2.29861124 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.28808611 |
| 81 | Autoimmune thrombocytopenia (HP:0001973) | 2.27840655 |
| 82 | Bronchitis (HP:0012387) | 2.21154269 |
| 83 | Glomerulopathy (HP:0100820) | 2.19398162 |
| 84 | Hypertensive crisis (HP:0100735) | 2.18060466 |
| 85 | Eosinophilia (HP:0001880) | 2.17688791 |
| 86 | Malnutrition (HP:0004395) | 2.17446117 |
| 87 | Nasal polyposis (HP:0100582) | 2.17375171 |
| 88 | Skin ulcer (HP:0200042) | 2.15535490 |
| 89 | Abnormality of the pericardium (HP:0001697) | 2.14244609 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.13257126 |
| 91 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11727556 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11727556 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11727556 |
| 94 | Papilloma (HP:0012740) | 2.11658930 |
| 95 | Verrucae (HP:0200043) | 2.11658930 |
| 96 | B lymphocytopenia (HP:0010976) | 2.09411778 |
| 97 | Epistaxis (HP:0000421) | 2.08733736 |
| 98 | Acute hepatic failure (HP:0006554) | 2.05998189 |
| 99 | Abnormality of eosinophils (HP:0001879) | 2.02891595 |
| 100 | Abnormality of the nasal mucosa (HP:0000433) | 2.01767646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.74270793 |
| 2 | RIPK4 | 4.21768401 |
| 3 | IRAK4 | 3.40236239 |
| 4 | ERN1 | 3.19837851 |
| 5 | TXK | 2.67066123 |
| 6 | TYK2 | 2.51970873 |
| 7 | BLK | 2.50815137 |
| 8 | TLK1 | 2.41196784 |
| 9 | TBK1 | 2.35894902 |
| 10 | MAP3K14 | 2.35757874 |
| 11 | IKBKE | 2.18941686 |
| 12 | CSK | 2.16998446 |
| 13 | PRPF4B | 2.03884125 |
| 14 | GRK6 | 1.94326972 |
| 15 | SYK | 1.94208889 |
| 16 | JAK3 | 1.90289414 |
| 17 | FES | 1.87858126 |
| 18 | TESK2 | 1.83173372 |
| 19 | BTK | 1.80577908 |
| 20 | SMG1 | 1.70964519 |
| 21 | TNK2 | 1.68553033 |
| 22 | MAP3K13 | 1.65338215 |
| 23 | ZAP70 | 1.65078492 |
| 24 | EPHB1 | 1.64619850 |
| 25 | MAP2K3 | 1.61743649 |
| 26 | IKBKB | 1.61373130 |
| 27 | JAK1 | 1.61004453 |
| 28 | KIT | 1.58223731 |
| 29 | MAP3K11 | 1.55803266 |
| 30 | LYN | 1.45605081 |
| 31 | CSF1R | 1.45492189 |
| 32 | FGFR4 | 1.44222383 |
| 33 | SIK3 | 1.43622577 |
| 34 | VRK1 | 1.40573834 |
| 35 | ITK | 1.39930266 |
| 36 | HCK | 1.31164570 |
| 37 | LCK | 1.27415905 |
| 38 | KDR | 1.24288619 |
| 39 | MAP3K3 | 1.22343899 |
| 40 | BCKDK | 1.20058011 |
| 41 | TAOK1 | 1.17467188 |
| 42 | TAOK2 | 1.14840010 |
| 43 | EPHA3 | 1.12641264 |
| 44 | MATK | 1.07547784 |
| 45 | IRAK3 | 1.06935514 |
| 46 | TAOK3 | 1.05713121 |
| 47 | JAK2 | 1.04251278 |
| 48 | SIK2 | 1.03578048 |
| 49 | DAPK3 | 1.01630185 |
| 50 | PRKCQ | 0.98945449 |
| 51 | FGR | 0.94853881 |
| 52 | MAP3K1 | 0.94797785 |
| 53 | ZAK | 0.93187282 |
| 54 | BMPR2 | 0.92096864 |
| 55 | MARK3 | 0.85456306 |
| 56 | TEC | 0.83861803 |
| 57 | SIK1 | 0.78195654 |
| 58 | PDK1 | 0.73059378 |
| 59 | CDC42BPA | 0.72473887 |
| 60 | RPS6KA5 | 0.70331045 |
| 61 | IRAK1 | 0.69949882 |
| 62 | HIPK2 | 0.68714323 |
| 63 | PIM1 | 0.67621694 |
| 64 | CDK19 | 0.67568063 |
| 65 | FGFR3 | 0.60435437 |
| 66 | CHUK | 0.60014047 |
| 67 | STK10 | 0.58692328 |
| 68 | MAP2K6 | 0.56575432 |
| 69 | PTK6 | 0.54963755 |
| 70 | ARAF | 0.53175379 |
| 71 | FYN | 0.53074625 |
| 72 | MAPK11 | 0.52346256 |
| 73 | PDPK1 | 0.50775471 |
| 74 | MAPK7 | 0.50235081 |
| 75 | PRKD2 | 0.49594604 |
| 76 | PASK | 0.48174101 |
| 77 | TRIB3 | 0.44997117 |
| 78 | PRKCD | 0.43756391 |
| 79 | MAPK12 | 0.43103308 |
| 80 | MAPKAPK2 | 0.42351687 |
| 81 | GRK7 | 0.41689690 |
| 82 | TESK1 | 0.41095862 |
| 83 | KSR2 | 0.40841866 |
| 84 | MAP2K2 | 0.40506911 |
| 85 | PRKG2 | 0.40389634 |
| 86 | NEK9 | 0.36634336 |
| 87 | MAP3K8 | 0.34452736 |
| 88 | ALK | 0.33234063 |
| 89 | MAP3K5 | 0.32498071 |
| 90 | CDK4 | 0.30067063 |
| 91 | NLK | 0.27988763 |
| 92 | RPS6KC1 | 0.27843538 |
| 93 | RPS6KL1 | 0.27843538 |
| 94 | PRKCH | 0.26922672 |
| 95 | MAPKAPK3 | 0.24805918 |
| 96 | PIM2 | 0.24437087 |
| 97 | INSR | 0.23327480 |
| 98 | ABL1 | 0.23055218 |
| 99 | RPS6KA6 | 0.21951907 |
| 100 | LRRK2 | 0.21594077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.37263800 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.04577968 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.00081675 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.62949865 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.48053896 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.31744927 |
| 7 | Asthma_Homo sapiens_hsa05310 | 3.30767264 |
| 8 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.01159377 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.87911565 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.84166614 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.75787546 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.73060137 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.48893807 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02342138 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96571272 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.89913014 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85311532 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.85252706 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.75929641 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.68758472 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67275909 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66414773 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.64329453 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.58123623 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48305117 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44468339 |
| 27 | Alcoholism_Homo sapiens_hsa05034 | 1.32649320 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31775047 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29334175 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22358642 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21604628 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.20749097 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16217515 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.15671244 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15037014 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.12725604 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10251777 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09600997 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06608666 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98322485 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94600317 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 0.91428206 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89300167 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88925087 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85609315 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.84831088 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.83760047 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.83009111 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.80238385 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79864279 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.77559896 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.76502790 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76084235 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70366175 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66562911 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66540223 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57526248 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.53882195 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45445979 |
| 60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43771999 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.41564360 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37035388 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32816014 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.32375612 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31037194 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28245412 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26473073 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25609934 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23725359 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22840596 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22318196 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22247397 |
| 73 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.22094629 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20817989 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20262588 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20125394 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.19807052 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.17861449 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17623441 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.16524800 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15580217 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14842708 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.14703927 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.13754456 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.13292752 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.12365575 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.12269560 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.11958587 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.11388957 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.11049246 |
| 91 | Proteasome_Homo sapiens_hsa03050 | 0.10983641 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.10025550 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.08214324 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.05938666 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.04596576 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.03814082 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.03751826 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02492110 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.02461095 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.01062135 |

